nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models
|
Xu, Pengfei |
|
|
189 |
C |
p. |
artikel |
2 |
Artificial intelligence in liver cancers: Decoding the impact of machine learning models in clinical diagnosis of primary liver cancers and liver cancer metastases
|
Bakrania, Anita |
|
|
189 |
C |
p. |
artikel |
3 |
Autophagy as a self-digestion signal in human cancers: Regulation by microRNAs in affecting carcinogenesis and therapy response
|
Kadhim, Mustafa M. |
|
|
189 |
C |
p. |
artikel |
4 |
Biomarker discovery and application—An opportunity to resolve the challenge of liver cancer diagnosis and treatment
|
Chen, Jingtao |
|
|
189 |
C |
p. |
artikel |
5 |
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer
|
Mahmoud, Ali Mokhtar |
|
|
189 |
C |
p. |
artikel |
6 |
Corrigendum to ‘Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein’ [Pharmacol. Res. 175 (2022) 105975]
|
Abd-ellatef, Gamal Eldein Fathy |
|
|
189 |
C |
p. |
artikel |
7 |
Covalent targeting the LAS1-NOL9 axis for selective treatment in NPM1 mutant acute myeloid leukemia
|
Han, Yefan |
|
|
189 |
C |
p. |
artikel |
8 |
Deucravacitinib is an allosteric TYK2 protein kinase inhibitor FDA-approved for the treatment of psoriasis
|
Roskoski Jr., Robert |
|
|
189 |
C |
p. |
artikel |
9 |
Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis
|
Shi, Fu-li |
|
|
189 |
C |
p. |
artikel |
10 |
Dual inhibition of MYC and SLC39A10 by a novel natural product STAT3 inhibitor derived from Chaetomium globosum suppresses tumor growth and metastasis in gastric cancer
|
Guan, Xiaoqing |
|
|
189 |
C |
p. |
artikel |
11 |
Editorial Board
|
|
|
|
189 |
C |
p. |
artikel |
12 |
Gpr35 shapes gut microbial ecology to modulate hepatic steatosis
|
Wu, Xin |
|
|
189 |
C |
p. |
artikel |
13 |
Gut microbiota remodeling improves natural aging-related disorders through Akkermansia muciniphila and its derived acetic acid
|
Ma, Junli |
|
|
189 |
C |
p. |
artikel |
14 |
Identification of a novel heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) ligand that disrupts HnRNPA2B1/nucleic acid interactions to inhibit the MDMX-p53 axis in gastric cancer
|
Hu, Lei |
|
|
189 |
C |
p. |
artikel |
15 |
IgD/FcδR is involved in T-cell acute lymphoblastic leukemia and regulated by IgD-Fc-Ig fusion protein
|
Wu, Yujing |
|
|
189 |
C |
p. |
artikel |
16 |
Integrating network analysis and experimental validation to reveal the mitophagy-associated mechanism of Yiqi Huoxue (YQHX) prescription in the treatment of myocardial ischemia/reperfusion injury
|
Chen, Mingtai |
|
|
189 |
C |
p. |
artikel |
17 |
Liraglutide abrogates nephrotoxic effects of chemotherapies
|
Xu, Cong |
|
|
189 |
C |
p. |
artikel |
18 |
m6A methylation-induced NR1D1 ablation disrupts the HSC circadian clock and promotes hepatic fibrosis
|
Chen, Li |
|
|
189 |
C |
p. |
artikel |
19 |
Mast cells contribute to the resolution of allergic inflammation by releasing resolvin D1
|
Puzzovio, Pier Giorgio |
|
|
189 |
C |
p. |
artikel |
20 |
Meeting vaccine formulation challenges in an emergency setting: Towards the development of accessible vaccines
|
Peletta, Allegra |
|
|
189 |
C |
p. |
artikel |
21 |
Nicotinic acetylcholine receptors and epilepsy
|
Becchetti, Andrea |
|
|
189 |
C |
p. |
artikel |
22 |
Novel therapeutic strategies targeting UCP2 in uterine leiomyosarcoma
|
Nagao, Yukari |
|
|
189 |
C |
p. |
artikel |
23 |
Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)
|
Rizzo, Manfredi |
|
|
189 |
C |
p. |
artikel |
24 |
Oncolytic adenovirus-mediated expression of CCL5 and IL12 facilitates CA9-targeting CAR-T therapy against renal cell carcinoma
|
Fang, Lin |
|
|
189 |
C |
p. |
artikel |
25 |
Quantitative assessment of translocator protein (TSPO) in the non-human primate brain and clinical translation of [18F]LW223 as a TSPO-targeted PET radioligand
|
Tan, Zhiqiang |
|
|
189 |
C |
p. |
artikel |
26 |
Reply to SGLT-2 inhibitors: Post-infarction interventional effects
|
Paolisso, Pasquale |
|
|
189 |
C |
p. |
artikel |
27 |
Repositioning of Cefuroxime as novel selective inhibitor of the thyroid hormone activating enzyme type 2 deiodinase
|
Sagliocchi, Serena |
|
|
189 |
C |
p. |
artikel |
28 |
SGLT-2 inhibitors: Post infarction interventional effects
|
Thangaraju, Pugazhenthan |
|
|
189 |
C |
p. |
artikel |
29 |
Sigma-1 receptor modulation fine-tunes KV1.5 channels and impacts pulmonary vascular function
|
Vera-Zambrano, Alba |
|
|
189 |
C |
p. |
artikel |
30 |
The challenges and opportunities of αvβ3-based therapeutics in cancer: From bench to clinical trials
|
Gu, Yanlun |
|
|
189 |
C |
p. |
artikel |
31 |
USP11 plays a critical role in the onset and progression of acute graft-versus-host disease:Novel target for precision therapeutics
|
Wang, Rongrong |
|
|
189 |
C |
p. |
artikel |